Shares of Guardant Health Inc. (GH) fell sharply by 5.11% in the pre-market session on Friday, as the company reported disappointing financial results for the quarter ended December 31, 2024.
According to the earnings report, Guardant Health posted an adjusted loss of $0.90 per share, missing analysts' expectations of a loss of $0.74 per share. The company's revenue grew 30.2% year-over-year to $201.81 million, but still fell short of the consensus estimate of $192.14 million.
The disappointing earnings performance and failure to meet Wall Street's estimates appear to have triggered the sharp sell-off in Guardant Health's stock. Investors may have concerns about the company's profitability and growth prospects, as it continues to report significant losses despite revenue growth.